Gujarat Themis Biosyn standalone net profit rises 69.08% in the March 2022 quarter

Sales rise 23.43% to Rs 28.76 crore

Net profit of Gujarat Themis Biosyn rose 69.08% to Rs 9.79 crore in the quarter ended March 2022 as against Rs 5.79 crore during the previous quarter ended March 2021. Sales rose 23.43% to Rs 28.76 crore in the quarter ended March 2022 as against Rs 23.30 crore during the previous quarter ended March 2021.

For the full year,net profit rose 44.53% to Rs 43.62 crore in the year ended March 2022 as against Rs 30.18 crore during the previous year ended March 2021. Sales rose 26.82% to Rs 114.85 crore in the year ended March 2022 as against Rs 90.56 crore during the previous year ended March 2021.

ParticularsQuarter EndedYear EndedMar. 2022Mar. 2021% Var.Mar. 2022Mar. 2021% Var.Sales28.7623.30 23 114.8590.56 27 OPM %45.4835.62 -50.5444.53 - PBDT14.418.81 64 61.2642.62 44 PBT13.878.14 70 59.0340.89 44 NP9.795.79 69 43.6230.18 45

Powered by Capital Market - Live News